320 related articles for article (PubMed ID: 3468176)
21. Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS.
Lange JM; Paul DA; Huisman HG; de Wolf F; van den Berg H; Coutinho RA; Danner SA; van der Noordaa J; Goudsmit J
Br Med J (Clin Res Ed); 1986 Dec; 293(6560):1459-62. PubMed ID: 3099912
[TBL] [Abstract][Full Text] [Related]
22. HIV antigen and antibody detection: variable responses to infection in the Edinburgh haemophiliac cohort.
Simmonds P; Lainson FA; Cuthbert R; Steel CM; Peutherer JF; Ludlam CA
Br Med J (Clin Res Ed); 1988 Feb; 296(6622):593-8. PubMed ID: 3126920
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic value of HIV-Ag testing and anti-p24 titers in HIV carriers and AIDS patients.
Roumeliotou A; Nestoridou E; Economidou I; Psarra E; Sidiri E; Choremi E; Kallinikos G; Papaevangelou G
AIDS; 1988 Feb; 2(1):64. PubMed ID: 3129002
[No Abstract] [Full Text] [Related]
24. Will antibody-dependent enhancement of HIV-1 infection be a problem with AIDS vaccines?
Robinson WE; Montefiori DC; Mitchell WM
Lancet; 1988 Apr; 1(8589):830-1. PubMed ID: 2895350
[No Abstract] [Full Text] [Related]
25. Detection of HIV envelope specific antibodies by immunoelectron microscopy and correlation with antibody titer and virus neutralizing activity.
Hausmann EH; Gelderblom HR; Clapham PR; Pauli G; Weiss RA
J Virol Methods; 1987 May; 16(1-2):125-37. PubMed ID: 3038935
[TBL] [Abstract][Full Text] [Related]
26. Serological markers in early stages of human immunodeficiency virus infection in haemophiliacs.
Allain JP; Laurian Y; Paul DA; Senn D
Lancet; 1986 Nov; 2(8518):1233-6. PubMed ID: 2878129
[TBL] [Abstract][Full Text] [Related]
27. Patterns of antigenaemia and antibody response in patients infected with human immunodeficiency virus (HIV) according to clinical state.
Re MC; Furlini G; La Placa M
J Clin Pathol; 1989 Mar; 42(3):282-3. PubMed ID: 2703545
[TBL] [Abstract][Full Text] [Related]
28. Persistent infection of chimpanzees with human immunodeficiency virus: serological responses and properties of reisolated viruses.
Nara PL; Robey WG; Arthur LO; Asher DM; Wolff AV; Gibbs CJ; Gajdusek DC; Fischinger PJ
J Virol; 1987 Oct; 61(10):3173-80. PubMed ID: 2442411
[TBL] [Abstract][Full Text] [Related]
29. Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex.
Archibald DW; Barr CE; Torosian JP; McLane MF; Essex M
J Infect Dis; 1987 Apr; 155(4):793-6. PubMed ID: 3469280
[No Abstract] [Full Text] [Related]
30. [Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients].
Schulte C; Meurer M; Braun-Falco O; Held M; Fröschl M
Klin Wochenschr; 1988 Jun; 66(11):488-93. PubMed ID: 3165484
[TBL] [Abstract][Full Text] [Related]
31. Specific antibody and virus antigen expression in congenital HIV infection.
Tovo PA; Gabiano C; Riva C; Palomba E; Valpreda A; Musso A
Lancet; 1987 May; 1(8543):1201. PubMed ID: 2883510
[No Abstract] [Full Text] [Related]
32. Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection.
Forster SM; Osborne LM; Cheingsong-Popov R; Kenny C; Burnell R; Jeffries DJ; Pinching AJ; Harris JR; Weber JN
AIDS; 1987 Dec; 1(4):235-40. PubMed ID: 3126771
[TBL] [Abstract][Full Text] [Related]
33. Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus.
Vujcic LK; Shepp DH; Klutch M; Wells MA; Hendry RM; Wittek AE; Krilov L; Quinnan GV
J Infect Dis; 1988 May; 157(5):1047-50. PubMed ID: 3162928
[No Abstract] [Full Text] [Related]
34. Characterization of serum neutralization response to the human immunodeficiency virus (HIV).
Groopman JE; Benz PM; Ferriani R; Mayer K; Allan JD; Weymouth LA
AIDS Res Hum Retroviruses; 1987; 3(1):71-85. PubMed ID: 2441727
[TBL] [Abstract][Full Text] [Related]
35. Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection.
Cao YZ; Valentine F; Hojvat S; Allain JP; Rubinstein P; Mirabile M; Czelusniak S; Leuther M; Baker L; Friedman-Kien AE
Blood; 1987 Aug; 70(2):575-8. PubMed ID: 2886162
[TBL] [Abstract][Full Text] [Related]
36. High prevalence of serum antibodies to reverse transcriptase in HIV-1-infected individuals.
DeVico AL; Veronese FD; Lee SL; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1988 Feb; 4(1):17-22. PubMed ID: 2452648
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and AIDS.
Tenner-Rácz K; Rácz P; Dietrich M; Kern P; Janossy G; Veronese-Dimarzo F; Klatzmann D; Gluckman JC; Popovic M
AIDS; 1987 Jul; 1(2):95-104. PubMed ID: 3130085
[TBL] [Abstract][Full Text] [Related]
38. Serological characterization of HTLV-III infection in AIDS and related disorders.
Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
[TBL] [Abstract][Full Text] [Related]
39. Neutralizing antibodies and the course of HIV-induced disease.
Wendler I; Bienzle U; Hunsmann G
AIDS Res Hum Retroviruses; 1987; 3(2):157-63. PubMed ID: 3650100
[TBL] [Abstract][Full Text] [Related]
40. Antibody to a synthetic oligopeptide in subjects at risk for human immunodeficiency virus infection.
Smith RS; Naso RB; Rosen J; Whalley A; Hom YL; Hoey K; Kennedy CJ; McCutchan JA; Spector SA; Richman DD
J Clin Microbiol; 1987 Aug; 25(8):1498-504. PubMed ID: 3476491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
